The invention relates to carboxamide derivatives as defined in the specification and claims, to a process for their preparation, to pharmaceutical compositions comprising them and to their use as mGluR1 enhancers in the treatment and prevention of neurological disorders and diseases, such as Alzheimer's disease and dementia.

 
Web www.patentalert.com

< Pharmaceutical compositions containing plasma protein

< Sulfonamides as potassium channel blockers

> Indazole or indole derivatives, and use thereof in human medicine and more particularly in oncology

> Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
~ 00294